These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible. Zschoche C; Bidier M; Hadaschik E J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686 [No Abstract] [Full Text] [Related]
3. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis. Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677 [No Abstract] [Full Text] [Related]
4. Generalized pustular psoriasis-like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis. Kimura U; Kinoshita A; Haruna K; Mizuno Y; Sekigawa I; Takamori K; Suga Y J Dermatol; 2012 Mar; 39(3):286-7. PubMed ID: 21957978 [No Abstract] [Full Text] [Related]
5. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069 [No Abstract] [Full Text] [Related]
6. A case of nail psoriasis-associated psoriatic arthritis successfully treated with adalimumab. Ikumi N; Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Kuwana Y; Matsukawa Y; Hayama T; Sawada S; Takei M; Ochiai T Acta Dermatovenerol Croat; 2014; 22(1):65-6. PubMed ID: 24813847 [No Abstract] [Full Text] [Related]
7. Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology. Neri P; Zucchi M; Allegri P; Lettieri M; Mariotti C; Giovannini A Int Ophthalmol; 2011 Apr; 31(2):165-73. PubMed ID: 21287227 [TBL] [Abstract][Full Text] [Related]
8. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis. Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916 [TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047 [TBL] [Abstract][Full Text] [Related]
10. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299 [TBL] [Abstract][Full Text] [Related]
11. Adalimumab therapy for refractory uveitis: a pilot study. Callejas-Rubio JL; Sánchez-Cano D; Serrano JL; Ortego-Centeno N J Ocul Pharmacol Ther; 2008 Dec; 24(6):613-4; author reply 614. PubMed ID: 19049264 [No Abstract] [Full Text] [Related]